Technological development and production of health supplies: challenges for the Unified Health System (SUS)
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Bioscience journal (Online) |
Texto Completo: | https://seer.ufu.br/index.php/biosciencejournal/article/view/41808 |
Resumo: | This study discusses the Brazilian model of incentives for the domestic development and production of supplies for public health, considering initiatives implemented from 2003 to 2016. This paper was prepared based on a qualitative bibliographic study, considering authors in the fields of health sciences, public health and public policy, reports by the World Health Organization (WHO), the Organization for Economic Cooperation and Development (OECD), Inter-American Development Bank (IDB) and the World Trade Organization (WTO), and official documents available from the Brazilian Federal Government. The paper focuses on the social dimension of health, considering a specific time period in the literature, from 2003 to 2016 and, finally, the new Regulatory Framework for Science, Technology, and Innovation approved in 2016. Various government initiatives were identified in the field of technological development and production to meet the objectives of the SUS according to the literature analysis. Brazil has been substantially increasing investment in Research and Development (R&D) during the last decade, though it lags European and OECD counterparts. Brazilian investment in R&D increased from 1.01% of gross domestic product (GDP) in 2000 to 1.23% in 2012. Despite being the top performer in Latin America (representing 60% of total R&D investment in the region), investment in R&D in Brazil is approximately half the level of European and OECD countries, which invest on average approximately 2% and 2.5% of GDP. |
id |
UFU-14_f46d2cc725dec4e26f624c197f3f704e |
---|---|
oai_identifier_str |
oai:ojs.www.seer.ufu.br:article/41808 |
network_acronym_str |
UFU-14 |
network_name_str |
Bioscience journal (Online) |
repository_id_str |
|
spelling |
Technological development and production of health supplies: challenges for the Unified Health System (SUS) Desenvolvimento tecnológico e produção de insumos para saúde: desafios para o sistema único de saúde (SUS)Health sciencesPublic healthBiosciencesPublic policiesInnovationHealth SciencesThis study discusses the Brazilian model of incentives for the domestic development and production of supplies for public health, considering initiatives implemented from 2003 to 2016. This paper was prepared based on a qualitative bibliographic study, considering authors in the fields of health sciences, public health and public policy, reports by the World Health Organization (WHO), the Organization for Economic Cooperation and Development (OECD), Inter-American Development Bank (IDB) and the World Trade Organization (WTO), and official documents available from the Brazilian Federal Government. The paper focuses on the social dimension of health, considering a specific time period in the literature, from 2003 to 2016 and, finally, the new Regulatory Framework for Science, Technology, and Innovation approved in 2016. Various government initiatives were identified in the field of technological development and production to meet the objectives of the SUS according to the literature analysis. Brazil has been substantially increasing investment in Research and Development (R&D) during the last decade, though it lags European and OECD counterparts. Brazilian investment in R&D increased from 1.01% of gross domestic product (GDP) in 2000 to 1.23% in 2012. Despite being the top performer in Latin America (representing 60% of total R&D investment in the region), investment in R&D in Brazil is approximately half the level of European and OECD countries, which invest on average approximately 2% and 2.5% of GDP.Este artigo pretende discutir o modelo brasileiro de incentivos para o desenvolvimento interno e produção de insumos para saúde pública, considerando ações governamentais implementadas no período de 2003 a 2016. O artigo foi elaborado com base em estudo bibliográfico qualitativo, considerando autores nas áreas de economia da saúde, saúde pública e políticas públicas, relatórios da Organização Mundial de Saúde (OMS), Organização para a Cooperação e Desenvolvimento Econômico (OCDE), Banco Interamericano de Desenvolvimento (IDB) e Organização Mundial do Comércio (OMC), bem como documentos oficiais disponíveis do Governo Federal Brasileiro. O estudo aborda a dimensão social da saúde, considerando um período de tempo específico na literatura, de 2003 a 2016 e, finalmente, o novo Marco Legal da Ciência, Tecnologia e Inovação aprovado em 2016. Diversas iniciativas governamentais para atingir os objetivosdo SUS foram identificadas, de acordo com a análise da literatura. O Brasil tem aumentado substancialmente o investimento em Pesquisa e Desenvolvimento (P & D) durante a última década, embora fique atrás de países europeus e da OCDE. O investimento brasileiro em P & D aumentou de 1,01% do produto interno bruto (PIB) em 2000 para 1,23% em 2012. Apesar de ter o melhor desempenho na América Latina (representando 60% do investimento total em P & D na região), o investimento em P & D no Brasil é aproximadamente metade do nível dos países europeus e da OCDE, que investem em média aproximadamente 2% e 2,5% do PIB.EDUFU2018-10-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://seer.ufu.br/index.php/biosciencejournal/article/view/4180810.14393/BJ-v34n5a2018-41808Bioscience Journal ; Vol. 34 No. 5 (2018): Sept./Oct.; 1402-1413Bioscience Journal ; v. 34 n. 5 (2018): Sept./Oct.; 1402-14131981-3163reponame:Bioscience journal (Online)instname:Universidade Federal de Uberlândia (UFU)instacron:UFUenghttps://seer.ufu.br/index.php/biosciencejournal/article/view/41808/24274Brazil; ContemporaryCopyright (c) 2018 Carlos Eduardo de Andrade Lima da Rocha, Fabio Kurt Schneiderhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessda Rocha, Carlos Eduardo de Andrade LimaSchneider, Fabio Kurt2022-02-10T17:46:16Zoai:ojs.www.seer.ufu.br:article/41808Revistahttps://seer.ufu.br/index.php/biosciencejournalPUBhttps://seer.ufu.br/index.php/biosciencejournal/oaibiosciencej@ufu.br||1981-31631516-3725opendoar:2022-02-10T17:46:16Bioscience journal (Online) - Universidade Federal de Uberlândia (UFU)false |
dc.title.none.fl_str_mv |
Technological development and production of health supplies: challenges for the Unified Health System (SUS) Desenvolvimento tecnológico e produção de insumos para saúde: desafios para o sistema único de saúde (SUS) |
title |
Technological development and production of health supplies: challenges for the Unified Health System (SUS) |
spellingShingle |
Technological development and production of health supplies: challenges for the Unified Health System (SUS) da Rocha, Carlos Eduardo de Andrade Lima Health sciences Public health Biosciences Public policies Innovation Health Sciences |
title_short |
Technological development and production of health supplies: challenges for the Unified Health System (SUS) |
title_full |
Technological development and production of health supplies: challenges for the Unified Health System (SUS) |
title_fullStr |
Technological development and production of health supplies: challenges for the Unified Health System (SUS) |
title_full_unstemmed |
Technological development and production of health supplies: challenges for the Unified Health System (SUS) |
title_sort |
Technological development and production of health supplies: challenges for the Unified Health System (SUS) |
author |
da Rocha, Carlos Eduardo de Andrade Lima |
author_facet |
da Rocha, Carlos Eduardo de Andrade Lima Schneider, Fabio Kurt |
author_role |
author |
author2 |
Schneider, Fabio Kurt |
author2_role |
author |
dc.contributor.author.fl_str_mv |
da Rocha, Carlos Eduardo de Andrade Lima Schneider, Fabio Kurt |
dc.subject.por.fl_str_mv |
Health sciences Public health Biosciences Public policies Innovation Health Sciences |
topic |
Health sciences Public health Biosciences Public policies Innovation Health Sciences |
description |
This study discusses the Brazilian model of incentives for the domestic development and production of supplies for public health, considering initiatives implemented from 2003 to 2016. This paper was prepared based on a qualitative bibliographic study, considering authors in the fields of health sciences, public health and public policy, reports by the World Health Organization (WHO), the Organization for Economic Cooperation and Development (OECD), Inter-American Development Bank (IDB) and the World Trade Organization (WTO), and official documents available from the Brazilian Federal Government. The paper focuses on the social dimension of health, considering a specific time period in the literature, from 2003 to 2016 and, finally, the new Regulatory Framework for Science, Technology, and Innovation approved in 2016. Various government initiatives were identified in the field of technological development and production to meet the objectives of the SUS according to the literature analysis. Brazil has been substantially increasing investment in Research and Development (R&D) during the last decade, though it lags European and OECD counterparts. Brazilian investment in R&D increased from 1.01% of gross domestic product (GDP) in 2000 to 1.23% in 2012. Despite being the top performer in Latin America (representing 60% of total R&D investment in the region), investment in R&D in Brazil is approximately half the level of European and OECD countries, which invest on average approximately 2% and 2.5% of GDP. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-10-11 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufu.br/index.php/biosciencejournal/article/view/41808 10.14393/BJ-v34n5a2018-41808 |
url |
https://seer.ufu.br/index.php/biosciencejournal/article/view/41808 |
identifier_str_mv |
10.14393/BJ-v34n5a2018-41808 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://seer.ufu.br/index.php/biosciencejournal/article/view/41808/24274 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Carlos Eduardo de Andrade Lima da Rocha, Fabio Kurt Schneider https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Carlos Eduardo de Andrade Lima da Rocha, Fabio Kurt Schneider https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.coverage.none.fl_str_mv |
Brazil; Contemporary |
dc.publisher.none.fl_str_mv |
EDUFU |
publisher.none.fl_str_mv |
EDUFU |
dc.source.none.fl_str_mv |
Bioscience Journal ; Vol. 34 No. 5 (2018): Sept./Oct.; 1402-1413 Bioscience Journal ; v. 34 n. 5 (2018): Sept./Oct.; 1402-1413 1981-3163 reponame:Bioscience journal (Online) instname:Universidade Federal de Uberlândia (UFU) instacron:UFU |
instname_str |
Universidade Federal de Uberlândia (UFU) |
instacron_str |
UFU |
institution |
UFU |
reponame_str |
Bioscience journal (Online) |
collection |
Bioscience journal (Online) |
repository.name.fl_str_mv |
Bioscience journal (Online) - Universidade Federal de Uberlândia (UFU) |
repository.mail.fl_str_mv |
biosciencej@ufu.br|| |
_version_ |
1797069079573430272 |